Ready to find the sweet truth of honey?
Honey, a flavorful and nutritious food produced by honeybees, is widely consumed due to its antioxidant, antimicrobial, and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids…
The drug, known as LY-CoV1404 or Bebtelovimab, "potently" neutralised engineered versions of numerous variants, including Alpha,…
Moderna improves forecast for 2022 sales for COVID-19 vaccine
The company in November said its sales could be in the range of $17 billion to $22 billion in 2022
ICMR refuses using Molnupiravir for COVID treatment, pulmonologists disagree
Dr Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for…
New study shows novel strategy to improve quality checking of generic drugs
The strategy is likely to improve the regulatory and decision-making aspects related to pharmaceutical products
S.M.A.R.T Pharmaceuticals 2021-2030
Dr Ajaz Hussain, PhD and independent adviser, explains how to make common sense a SMART factory as the political and regulatory…
Caris Life Sciences and HotSpot Therapeutics collaborate to advance precision medicine development…
The partnership with Caris will streamline development of HotSpot’s portfolio by integrating broad tissue and liquid molecular…
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep
The secondary endpoint of hospitalisation and/or ER visits related to COVID-19, or death showed an overall 78 per cent reduction…
Pfizer partners with Beam Therapeutics to develop rare disease therapies
Beam will receive $300 million in upfront payment and lead research activities till three new therapy targets are selected for…
Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology
The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M)…